You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

Returns | 1W : -0.9% , 1M : 3%,1Y : 9.7%
www.torrentpharma.com
BOM : 500420     NSE : TORNTPHARM    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Sep 17,2021
Price(EOD): Rs. 3,096.45
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Affiliate Link.
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
TORRENT PHARMACEUTICALS -0.9% 3% 9.7%
SUN PHARMACEUTICAL INDUSTRIES -1.3% -1.8% 54.5%
DR REDDYS LABORATORIES -0.9% 4% 12.1%
DIVIS LABORATORIES 0.8% 4.4% 63.9%
CIPLA 0.4% 5.5% 31.5%
BIOCON 6.8% 2.9% -12.9%
AUROBINDO PHARMA 1.3% 2% -6%
LUPIN -3.4% -2.4% 0.1%
CADILA HEALTHCARE 0.5% 5% 52.5%


FUNDAMENTAL ANALYSIS OF TORRENT PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Jun2021, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]
Show Me the Stocks with Fundamentals better than TORRENT PHARMACEUTICALS Plus/Pro


VALUATION OF TORRENT PHARMACEUTICALS

 
Valuation Score
[As on : Sep 17,2021 ]

Ratio Consolidated
P/E
P/B
P/S
41.86
P/E Calculated based on EPS of 73.97
[ Mar2021 - Consolidated Results ]

8.98
P/B Calculated based on Book Value of 344.9
[ Mar2021 - Consolidated Results ]

6.48
P/S Calculated based on Revenues of 8083 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than TORRENT PHARMACEUTICALS Plus/Pro


FAIR VALUE OF TORRENT PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
168%
24%
2%

SHARE PRICE MOMENTUM OF TORRENT PHARMACEUTICALS

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.73
1.04
1.12
0.96
0.84
1.21
1.28
1.11
[Last Annual Data : Mar2021]

PLEDGED SHARES

Pledged Shares
0 %
As on : Jun2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
10.17%
16.32%
26.37%
1.85%
3.79%
2.42%
20.4%
2.8%
QtrlyTrend
8
Latest Qtr: Jun2021

TORRENT PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
S&P BSE SENSEX NEXT 50 1.5% 7.4% 61.5%
S&P BSE CARBONEX 1.4% 5.8% 54.6%
S&P BSE MIDCAP SELECT INDEX 1.4% 7.5% 67.4%
S&P BSE 100 1.3% 6% 54.9%
S&P BSE LARGE MIDCAP 1.3% 6.3% 56.5%
S&P BSE 200 1.2% 6.4% 57.7%
S&P BSE 100 LARGECAP TMC 1.2% 6.4% 54.9%
S&P BSE 250 LARGEMIDCAP 1.2% 6.4% 58.2%
S&P BSE ALLCAP 1.2% 6.3% 61.2%
S&P BSE 500 1.2% 6.4% 60%
S&P BSE MID CAP 1.1% 8.6% 72.8%
S&P BSE MIDSMALLCAP 0.8% 7.5% 84%
S&P BSE HEALTHCARE -0.2% 1.3% 42.6%
S&P BSE LOW VOLATILITY -0.5% 5.1% 47.5%
NSE Indices1W1M1Y
NIFTY LARGE MIDCAP 250 1.3% 7% 65.9%
NIFTY 200 1.3% 6.6% 57.6%
NIFTY 100 1.2% 6.3% 54.7%
NIFTY 500 1.2% 6.5% 59.9%
NIFTY500 MULTICAP 50:25:25 1% 6.6% NA
NIFTY NEXT 50 0.6% 8.6% 59.5%
NIFTY ALPHA LOW-VOLATILTY 30 0.2% 8.1% 51.8%
NIFTY PHARMA -0.2% 2.2% 28.1%
NIFTY HEALTHCARE -0.3% 1.2% NA

FAQ [Frequently Asked Questions]


Is TORRENT PHARMACEUTICALS good for long term investment?

As on 17-Sep-2021, the Fundamentals of TORRENT PHARMACEUTICALS look Strong and hence it may be good for long term investment! See Financial Performance of TORRENT PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is TORRENT PHARMACEUTICALS UnderValued or OverValued?

As on 17-Sep-2021, TORRENT PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of TORRENT PHARMACEUTICALS ?

As on 17-Sep-2021, the Intrinsic Value of TORRENT PHARMACEUTICALS is Rs. 2,493.93 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 1,153.90
Fair Value [Median EV / Sales Model] : Rs. 2,493.93
Fair Value [Median Price / Sales Model] : Rs. 3,047.71
Median Fair Value of TORRENT PHARMACEUTICALS : Rs. 2,493.93

Is TORRENT PHARMACEUTICALS trading at a Premium or Discount?

As on 17-Sep-2021, TORRENT PHARMACEUTICALS is trading at a Premium of 24% based on the estimates of Median Intrinsic Value!

What is the Financial Performance of Industry Peers of TORRENT PHARMACEUTICALS ?

Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of BIOCON LTD

What are the Frequent Comparisons in this Industry?

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD vs DIVIS LABORATORIES LTD
CIPLA LTD vs BIOCON LTD vs AUROBINDO PHARMA LTD
LUPIN LTD vs TORRENT PHARMACEUTICALS LTD vs CADILA HEALTHCARE LTD
ABBOTT INDIA LTD vs ALKEM LABORATORIES LTD vs PIRAMAL ENTERPRISES LTD
GLAXOSMITHKLINE PHARMACEUTICALS LTD vs IPCA LABORATORIES LTD vs PFIZER LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of BIOCON LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z